全新中西药配伍禁忌表

2019-10-22 佚名 基层医师公社综合整理

中西药联用是目前普遍采取的用药方式,且疗效显着。但我们在联合用药的过程中,如果不注意药物之间的不良反应,轻则减效或无效,重则导致中毒甚至死亡,所以临床上必须引起重视。

中西药联用是目前普遍采取的用药方式,且疗效显着。但我们在联合用药的过程中,如果不注意药物之间的不良反应,轻则减效或无效,重则导致中毒甚至死亡,所以临床上必须引起重视。

下面这份表格,罗列了最常见的中西药配伍禁忌,适合所有医生收藏。






版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1942407, encodeId=ca24194240e1d, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Jul 26 07:58:00 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545116, encodeId=a8c815451163e, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Oct 23 17:58:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555629, encodeId=f1ca155562941, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Wed Oct 23 17:58:00 CST 2019, time=2019-10-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1942407, encodeId=ca24194240e1d, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Jul 26 07:58:00 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545116, encodeId=a8c815451163e, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Oct 23 17:58:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555629, encodeId=f1ca155562941, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Wed Oct 23 17:58:00 CST 2019, time=2019-10-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1942407, encodeId=ca24194240e1d, content=<a href='/topic/show?id=c96d9543365' target=_blank style='color:#2F92EE;'>#配伍禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95433, encryptionId=c96d9543365, topicName=配伍禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Jul 26 07:58:00 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545116, encodeId=a8c815451163e, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Oct 23 17:58:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555629, encodeId=f1ca155562941, content=<a href='/topic/show?id=dcd89053994' target=_blank style='color:#2F92EE;'>#西药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90539, encryptionId=dcd89053994, topicName=西药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4014636852, createdName=minzju5057, createdTime=Wed Oct 23 17:58:00 CST 2019, time=2019-10-23, status=1, ipAttribution=)]
    2019-10-23 minzju5057

相关资讯

J Am Heart Assoc:万名急性心衰患者研究称:75%用中药,丹参或增死亡和出血风险

《美国心脏协会杂志》发表的一项针对China PEACE回顾性心衰研究的分析结果表明,在我国急性心衰住院患者中,74.7%应用中药,其中83.3%是静脉注射液。

这些中药大品种,被重点监控

截至目前,全国范围的三级公立医院落实绩效考核方案,限制辅助用药使用,与此同时,已有多地出台地方版重点监控目录,其在国家版的基础上扩充品种数量,覆盖了不少中药品种。

理想的中药出口日本欧洲,绝大部分中国人吃不到

出口的一批枸杞,在欧洲因为农药残留不合格而被扣留。对于李贵这种小型的药材出口公司而言,“自动扣留”无疑杀伤力巨大。

网络药理学:中药现代化的创新路径

近年来,网络药理学已成为中医药研究领域的一个前沿和热点,该研究方法能有效预测药物有效成分、作用靶点和毒副作用等,有利于推进中医药现代化的进程。

中药注射剂进入生死局 安全性再评价或成出路

中药注射剂是我国中医药特色产物,是中药现代化发展过程中的产物之一。中药注射剂参照注射剂的标准,从中药材(单味或复方)中提取某些活性组分、有效部位或有效成分作为原料研制而成。其安全性一直饱受争议,退市呼声不绝于耳,通过安全性再评价实现产品的优胜劣汰,或成为中药注射剂产业走出困境的唯一出路。

官方文件流出:这些西医,可以开中药了

这些西医,可以开中药了。